Basic Information
RNALocate ID: RLID:01002631
RNA Symbol: hsa-miR-340-5p
Localization: Mitochondrion
RNA Information
RNA Name: hsa-miR-340
RNA ID: miRBase:MIMAT0004692
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 22984580
Tissue/Cell Line: Cell line (HEK-293|HeLa)
Method: Next-generation RNA sequencing
Description: The differential association of miRNA to mitochondria of both HEK293 and HeLa has been summarized in Table S3. Data are collected from Table S3: Pattern of miRNAs associated with mitochondria of HEK293 and HeLa.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11003895 Exosome Serum 29143228
RLID:11003896 Exosome Serum 18589210
RLID:11003897 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11003898 Exosome Brain tissue 23382797
RLID:11003899 Exosome Plasma 23663360
RLID:11003900 Exosome Human mast cell line (HMC-1) 24009880
RLID:11003901 Exosome B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells 25242326
RLID:11003902 Extracellular vesicle HEK-293T cells 22849433
RLID-D:11000198 Exosome Blood|Breast milk|Endothelial cells|Mast cells|Seminal fluid|Tongue tissue
RLID-D:11000664 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-340-5p Multiple sclerosis chronic progressive MNDR-E-MI-41928
MNDR hsa-miR-340-5p Rheumatic heart diseases MNDR-E-MI-41929
MNDR hsa-miR-340-5p Oral squamous cell carcinoma MNDR-E-MI-41930
MNDR hsa-miR-340-5p Medulloblastoma MNDR-E-MI-41931
MNDR hsa-miR-340-5p Lymphoma MNDR-E-MI-41932
MNDR hsa-miR-340-5p Estrogen-receptor positive breast cancer MNDR-E-MI-41933
MNDR hsa-miR-340-5p Estrogen-receptor negative breast cancer MNDR-E-MI-41934
MNDR hsa-miR-340-5p Progesterone-receptor positive breast cancer MNDR-E-MI-41935
MNDR hsa-miR-340-5p Progesterone-receptor negative breast cancer MNDR-E-MI-41936
MNDR hsa-miR-340-5p Her2-receptor positive breast cancer MNDR-E-MI-41937
MNDR hsa-miR-340-5p Triple negative breast cancer MNDR-E-MI-41938
MNDR hsa-miR-340-5p Breast cancer luminal MNDR-E-MI-41939
MNDR hsa-miR-340-5p Dermatomyositis MNDR-E-MI-41940
MNDR hsa-miR-340-5p Prostate cancer MNDR-E-MI-41941
MNDR hsa-miR-340-5p Gastric cancer MNDR-E-MI-41942
MNDR hsa-miR-340-5p Alzheimer disease MNDR-E-MI-41943
MNDR hsa-miR-340-5p Dysautonomia familial MNDR-E-MI-41944
MNDR hsa-miR-340-5p Huntington disease MNDR-E-MI-41945
MNDR hsa-miR-340-5p Cardiovascular disease MNDR-E-MI-41946
MNDR hsa-miR-340-5p Lung cancer MNDR-E-MI-41947
MNDR hsa-miR-340-5p Parkinson disease MNDR-E-MI-41948
MNDR hsa-miR-340-5p Basal-like breast cancer MNDR-E-MI-41949
MNDR hsa-miR-340-5p Thyroid cancer MNDR-E-MI-41950
MNDR hsa-miR-340-5p Pituitary neoplasms MNDR-E-MI-41951
MNDR hsa-miR-340-5p Pancreatic cancer MNDR-E-MI-41952
MNDR hsa-miR-340-5p Melanoma MNDR-E-MI-41953
MNDR hsa-miR-340-5p Colon cancer MNDR-E-MI-41954
MNDR hsa-miR-340-5p Colon adenocarcinoma MNDR-E-MI-41955
MNDR hsa-miR-340-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-41956
MNDR hsa-miR-340-5p Ovarian cancer MNDR-E-MI-41957
MNDR hsa-miR-340-5p Acromegaly MNDR-E-MI-41958
MNDR hsa-miR-340-5p Prostate adenocarcinoma MNDR-E-MI-41959
MNDR hsa-miR-340-5p Kidney cancer MNDR-E-MI-41960
MNDR hsa-miR-340-5p Carcinoma ductal breast MNDR-E-MI-41961
MNDR hsa-miR-340-5p Glioblastoma MNDR-E-MI-41962
MNDR hsa-miR-340-5p Glioma MNDR-E-MI-41963
MNDR hsa-miR-340-5p Neurilemmoma MNDR-E-MI-41964
MNDR hsa-miR-340-5p Central nervous system lymphoma MNDR-E-MI-41965
MNDR hsa-miR-340-5p Amyotrophic lateral sclerosis MNDR-E-MI-41966
MNDR hsa-miR-340-5p Epilepsy temporal lobe MNDR-E-MI-41967
MNDR hsa-miR-340-5p Coronary artery disease MNDR-E-MI-41968
MNDR hsa-miR-340-5p Inclusion body myositis MNDR-E-MI-41969
MNDR hsa-miR-340-5p Breast carcinoma MNDR-E-MI-41970
MNDR hsa-miR-340-5p Uterine cancer MNDR-E-MI-41971
MNDR hsa-miR-340-5p Pituitary adenoma MNDR-E-MI-41972
MNDR hsa-miR-340-5p Lung squamous cell carcinoma MNDR-E-MI-41973
MNDR hsa-miR-340-5p Lung adenocarcinoma MNDR-E-MI-41974
MNDR hsa-miR-340-5p Adrenocortical carcinoma MNDR-E-MI-41975
MNDR hsa-miR-340-5p Bladder urothelial carcinoma MNDR-E-MI-41976
MNDR hsa-miR-340-5p Carcinoma renal cell MNDR-E-MI-41977
MNDR hsa-miR-340-5p Kidney renal papillary cell carcinoma MNDR-E-MI-41978
MNDR hsa-miR-340-5p Renal clear cell carcinoma MNDR-E-MI-41979
MNDR hsa-miR-340-5p Cholangiocarcinoma MNDR-E-MI-41980
MNDR hsa-miR-340-5p Esophageal cancer MNDR-E-MI-41981
MNDR hsa-miR-340-5p Liver cirrhosis MNDR-E-MI-41982
MNDR hsa-miR-340-5p Lung small cell carcinoma MNDR-E-MI-41983
MNDR hsa-miR-340-5p Synovial sarcoma MNDR-E-MI-41984
MNDR hsa-miR-340-5p Head and neck squamous cell carcinoma MNDR-E-MI-41985
MNDR hsa-miR-340-5p Growth hormone-secreting pituitary adenoma MNDR-E-MI-41986
MNDR hsa-miR-340-5p Breast invasive carcinoma MNDR-E-MI-41987
MNDR hsa-miR-340-5p Early hepatocellular carcinoma MNDR-E-MI-41988
MNDR hsa-miR-340-5p Embryonal cancer MNDR-E-MI-41989
MNDR hsa-miR-340-5p Lymphoblastoid MNDR-E-MI-41990
MNDR hsa-miR-340-5p Rheumatoid arthritis MNDR-E-MI-41991
MNDR hsa-miR-340-5p Retinoblastoma MNDR-E-MI-41992
MNDR hsa-miR-340-5p Barrett's adenocarcinoma MNDR-E-MI-41993
MNDR hsa-miR-340-5p Hodgkin lymphoma MNDR-E-MI-41994
MNDR hsa-miR-340-5p Burkitt lymphoma MNDR-E-MI-41995
MNDR hsa-miR-340-5p Tonsil cancer MNDR-E-MI-41996
MNDR hsa-miR-340-5p Acute myeloid leukemia MNDR-E-MI-41997
MNDR hsa-miR-340-5p Colorectal cancer MNDR-E-MI-41998
MNDR hsa-miR-340-5p Nasopharynx carcinoma MNDR-E-MI-41999
MNDR hsa-miR-340-5p Multiple myeloma MNDR-E-MI-42000
MNDR hsa-miR-340-5p Nasopharyngeal cancer MNDR-E-MI-42001
MNDR hsa-miR-340-5p Stroke lacunar MNDR-E-MI-42002
MNDR hsa-miR-340-5p Barrett's carcinogenesis MNDR-E-MI-42003
MNDR hsa-miR-340-5p Breast cancer her3+ negative MNDR-E-MI-42004
MNDR hsa-miR-340-5p Low grade dysplastic nodule MNDR-E-MI-42005
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter BCL11A Homo sapiens RR00218496
TOP